Cite
McGill JB, Johnson M, Hurst S, et al. Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness. Diabetol Metab Syndr. 2019;11:61doi: 10.1186/s13098-019-0456-4.
McGill, J. B., Johnson, M., Hurst, S., Cade, W. T., Yarasheski, K. E., Ostlund, R. E., Schechtman, K. B., Razani, B., Kastan, M. B., McClain, D. A., de Las Fuentes, L., Davila-Roman, V. G., Ory, D. S., Wickline, S. A., & Semenkovich, C. F. (2019). Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness. Diabetology & metabolic syndrome, 1161. https://doi.org/10.1186/s13098-019-0456-4
McGill, Janet B, et al. "Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness." Diabetology & metabolic syndrome vol. 11 (2019): 61. doi: https://doi.org/10.1186/s13098-019-0456-4
McGill JB, Johnson M, Hurst S, Cade WT, Yarasheski KE, Ostlund RE, Schechtman KB, Razani B, Kastan MB, McClain DA, de Las Fuentes L, Davila-Roman VG, Ory DS, Wickline SA, Semenkovich CF. Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness. Diabetol Metab Syndr. 2019 Jul 29;11:61. doi: 10.1186/s13098-019-0456-4. eCollection 2019. PMID: 31384309; PMCID: PMC6664523.
Copy
Download .nbib